News
Publications
Multimedia
Conferences
Webcasts
Resources
Subscribe

Spotlight -

Drug Development|

Quality Systems

Horacio Pappa

Horacio Pappa is senior director, US Pharmacopeia.

Articles by Horacio Pappa

Paulista/stock.adobe.com – For high-risk analytical procedures, control-chart monitoring of selected performance data can provide early warning of changes in performance.

Ongoing Analytical Procedure Performance Verification—Stage 3 of USP<1220>

ByPhil Borman,Amanda Guiraldelli Mahr,Jane Weitzel,Sarah Thompson,Joachim Ermer,Stephanie Sproule,Jean-Marc Roussel,Jaime Marach,Horacio Pappa

March 2nd 2023

Analytical procedure performance can be continually verified by risk-based monitoring of performance related data.

Latest Updated Articles

Ongoing Analytical Procedure Performance Verification—Stage 3 of USP<1220>
Published: March 2nd 2023 | Updated:

Trending on Pharmaceutical Technology

FAQ: Key AI Applications in Drug Development

Industry Expert Panel Weighs CNPV Benefits, Risks, and Readiness: Part I

PharmTech Weekly News Roundup — Week of November 17, 2025

© 2025 MJH Life Sciences^®

All rights reserved.